These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 8255974)

  • 21. 5-Hydroxytryptamine and beta-adrenoceptors in rat isolated atria.
    Davy M; Grandcourt O; Midol-Monnet M; Cohen Y
    Cell Mol Life Sci; 1997 Mar; 53(3):263-6. PubMed ID: 9104489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-stimulated glycerol production from the isolated, perfused rat heart is mediated by non-adrenergic mechanisms.
    Wardle CA; Riemersma RA
    Basic Res Cardiol; 1994; 89(1):29-38. PubMed ID: 8010933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-adrenoceptor subtypes mediating the airways response to BRL 35135 in man.
    Newnham DM; Ingram CG; Mackie A; Lipworth BJ
    Br J Clin Pharmacol; 1993 Dec; 36(6):567-71. PubMed ID: 12959274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenoceptor Expression and Function in the Endocrine Pancreas.
    Dwaib H; Michel MC
    Handb Exp Pharmacol; 2024; 285():639-664. PubMed ID: 38872059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the β
    Dwaib HS; Michel MC
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity.
    Carey AL; Pajtak R; Formosa MF; Van Every B; Bertovic DA; Anderson MJ; Eikelis N; Lambert GW; Kalff V; Duffy SJ; Cherk MH; Kingwell BA
    Diabetologia; 2015 May; 58(5):1045-54. PubMed ID: 25725625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of a Beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor for the treatment of obesity.
    Jesudason CD; Baker JE; Bryant RD; Fisher JW; O'Farrell LS; Gaich GA; He MM; Kahl SD; Kriauciunas AV; Heiman ML; Peters MA; Rito CJ; Satterwhite JH; Tinsley FC; Trankle WG; Shuker AJ
    ACS Med Chem Lett; 2011 Aug; 2(8):583-6. PubMed ID: 24900353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.
    Arch JR
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):225-40. PubMed ID: 18612674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of adrenergic receptors and adrenergic functions in cold adapted humans.
    Janský L; Vybíral S; Trubacová M; Okrouhlík J
    Eur J Appl Physiol; 2008 Sep; 104(2):131-5. PubMed ID: 18060558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The beta 3-adrenergic system and beta 3-adrenergic agonists.
    Arch JR
    Rev Endocr Metab Disord; 2001 Oct; 2(4):385-93. PubMed ID: 11725725
    [No Abstract]   [Full Text] [Related]  

  • 31. Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle.
    Manara L; Croci T; Aureggi G; Guagnini F; Maffrand JP; Le Fur G; Mukenge S; Ferla G
    Gut; 2000 Sep; 47(3):337-42. PubMed ID: 10940268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise metabolism and beta-blocker therapy. An update.
    Head A
    Sports Med; 1999 Feb; 27(2):81-96. PubMed ID: 10091273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of high-throughput synthesis and purification in the preparation of a directed library of adrenergic agents.
    Siegel MG; Shuker AJ; Droste CA; Hahn PJ; Jesudason CD; McDonald JH; Matthews DP; Rito CJ; Thorpe AJ
    Mol Divers; 1997-1998; 3(2):113-6. PubMed ID: 9593180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.
    Wheeldon NM; McDevitt DG; Lipworth BJ
    Br J Clin Pharmacol; 1994 Apr; 37(4):363-9. PubMed ID: 7912539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of putative cardiac beta 3-adrenoceptors in man.
    Wheeldon NM; McDevitt DG; Lipworth BJ
    Q J Med; 1993 Apr; 86(4):255-61. PubMed ID: 8392210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.
    Haynes JM; Hill SJ
    Br J Pharmacol; 1997 Nov; 122(6):1067-74. PubMed ID: 9401771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man.
    Wheeldon NM; McDevitt DG; McFarlane LC; Lipworth BJ
    Clin Sci (Lond); 1994 Mar; 86(3):331-7. PubMed ID: 7908864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do beta 3-adrenoceptors mediate metabolic responses to isoprenaline.
    Wheeldon NM; McDevitt DG; Lipworth BJ
    Q J Med; 1993 Sep; 86(9):595-600. PubMed ID: 8255974
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.